Test Catalog
CTU - Overview: Creatinine, 24 Hour, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine
Detecting drug use involving stimulants, benzodiazepines, and opioids This test is not intended for use in employment-related testing.
C5DCU - Overview: C5-DC Acylcarnitine, Quantitative, Random, Urine
Evaluation of patients with an abnormal newborn screen showing elevations of glutarylcarnitine Diagnosis of glutaric aciduria type 1 deficiency
CRUO - Overview: Chromium Occupational Exposure, Random, Urine
Screening for occupational exposure
FCFS - Overview: Caspofungin Susceptibility Testing
Caspofungin Susceptibility Testing
RCHLU - Overview: Chloride, Random, Urine
An indicator of fluid balance and acid-base homeostasis
FCBDS - Overview: Cannabidiol, Serum
Cannabidiol, Serum
FCMEB - Overview: Carbon Monoxide Exposure, Blood
Carbon Monoxide Exposure, Blood
C3FX - Overview: C3 Complement, Functional, Serum
Diagnosis of C3 deficiency Investigation of a patient with undetectable total complement level
Monitoring acute (ie, short-term) drug use in addiction treatment or pain management settings as part of a rotational drug testing strategy Presumptive screening for amphetamine, methamphetamine, opioids/opiates (targeting morphine,...
CDA7X - Overview: Drug Abuse Survey with Confirmation, Panel 9, Chain of Custody, Random, Urine
Detecting drug abuse involving alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, phencyclidine, and tetrahydrocannabinol This chain-of-custody test is intended to be used in a setting where the test results...
DRVI3 - Overview: Dilute Russell's Viper Venom Time (DRVVT) Confirmation Ratio, Plasma
Confirming the presence or helping to exclude the presence of lupus anticoagulants (LA) Identifying LA that do not prolong the activated partial thromboplastin time (APTT) Evaluating unexplained prolongation of the APTT or prothrombin...
CRITH - Overview: DNA Double-Stranded (dsDNA) Antibodies by Crithidia luciliae IFA, IgG, Serum
Confirmation testing for dsDNA IgG antibodies in patients with clinical features of systemic lupus erythematosus or at-risk for disease This test should not be used independently for monitoring treatment response or establishing...
DRVI2 - Overview: Dilute Russell's Viper Venom Time (DRVVT) Mix Ratio, Plasma
Detecting the presence or helping to exclude the presence of lupus anticoagulants (LA) Identifying LA that do not prolong the activated partial thromboplastin time (APTT) Evaluating unexplained prolongation of the APTT or prothrombin...
DENGM - Overview: Dengue Virus Antibody, IgG and IgM, Serum
Aiding in the diagnosis of dengue virus infection
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
DMS2 - Overview: Dementia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating new onset dementia and cognitive impairment plus 1 or more of the following using serum specimens: -Rapid onset and progression -Fluctuating course -Psychiatric accompaniments (psychosis, hallucinations) -Movement disorder...
Establishing laboratory evidence of disseminated intravascular coagulation
DSGAB - Overview: Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibodies, Serum
Preferred screening test for patients suspected to have an autoimmune blistering disorder of the skin or mucous membranes (pemphigus) Aiding in the diagnosis of pemphigus
FDKYE - Overview: Dock Yellow (Rumex crispus) IgE
Dock Yellow (Rumex crispus) IgE
DRVI4 - Overview: Dilute Russell's Viper Venom Time (DRVVT) Interpretation
Interpreting mixing and confirmation assays for lupus anticoagulants
DMC2 - Overview: Dementia, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Investigating new onset dementia and cognitive impairment plus 1 or more of the following accompaniments using cerebrospinal fluid specimens: -Rapid onset and progression -Fluctuating course -Psychiatric accompaniments (psychosis,...
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
DHTS - Overview: Dihydrotestosterone, Serum
Monitoring patients receiving 5-alpha reductase inhibitor therapy or chemotherapy Evaluating patients with possible 5-alpha reductase deficiency
DBS1 - Overview: Diabetes Mellitus Type 1 Evaluation, Serum
Distinguishing type 1 from type 2 diabetes mellitus Identifying individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes) Predicting future insulin requirement treatment in patients with adult-onset...
Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors
DYS2 - Overview: Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum
Investigating idiopathic dysautonomic symptoms Directing a focused search for cancer in patients with idiopathic dysautonomia Investigating autonomic symptoms that appear in the course or wake of cancer therapy and are not explainable by...
DULOX - Overview: Duloxetine, Serum
Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance
FDGTX - Overview: Digitoxin, Serum
Digitoxin, Serum
FDXAP - Overview: Dexedrine (Dextroamphetamine)
Dexedrine (Dextroamphetamine)
DPYDZ - Overview: Dihydropyrimidine Dehydrogenase, DPYD Full Gene Sequencing, Varies
Identifying individuals at increased risk of toxicity when considering 5-fluorouracil and capecitabine chemotherapy treatment Identifying common and rare variants associated with decreased or absent dihydropyrimidine dehydrogenase (DPD)...
DEXT - Overview: Dermatopathology Consultation, Wet Tissue
Histologic diagnosis and differential diagnosis of cutaneous diseases
DDITT - Overview: D-Dimer, Plasma
Excluding the diagnosis of acute pulmonary embolism or deep vein thrombosis, particularly when results of a sensitive D-dimer assay are combined with clinical information, including pretest disease probability(1-4) Diagnosis of...
DAND - Overview: Dandelion, IgE, Serum
Establishing a diagnosis of an allergy to dandelion Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm sensitization prior...
DTABS - Overview: Diphtheria/Tetanus Antibody Panel, Serum
Assessing antibody response to tetanus and diphtheria toxoid vaccines, which should be performed at least 3 weeks after immunization Aiding in the evaluation of immunodeficiency This test should not be used to diagnose tetanus infection
DASM4 - Overview: Drugs of Abuse Screen, Meconium 4
Identifying amphetamines (and methamphetamines), opiates, as well as metabolites of cocaine and marijuana in meconium specimens
FDILT - Overview: Diltiazem (Cardizem, Dilacor)
Diltiazem (Cardizem, Dilacor)
DRPL - Overview: Dentatorubral-Pallidoluysian Atrophy (DRPLA) Gene Analysis, Varies
Confirming the diagnosis of dentatorubral-pallidoluysian atrophy (DRPLA) for symptomatic patients Predictive testing for individuals with a family history of DRPLA and a documented expansion in the ATN1 gene in an affected family member
DUCK - Overview: Duck Feathers, IgE, Serum
Establishing a diagnosis of an allergy to duck feathers Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm sensitization...
DSM5X - Overview: Drugs of Abuse Screen 5, Chain of Custody, Meconium
Identifying amphetamines (and methamphetamines), opiates, and phencyclidine, as well as metabolites of cocaine and marijuana in meconium specimens Chain of custody is required whenever the results of testing could be used in a court of...
DSM4X - Overview: Drugs of Abuse Screen 4, Chain of Custody, Meconium
Identifying amphetamines (and methamphetamines) and opiates, as well as metabolites of cocaine and marijuana in meconium specimen Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is...
FFRBS - Overview: Friedreich Ataxia, Frataxin, Quantitative, Blood Spot
Diagnosing individuals with Friedreich ataxia in blood spot specimens Monitoring frataxin levels in patients with Friedreich ataxia This test is not useful for carrier detection.
Providing a genetic evaluation for patients with a personal or family history of steroid resistant nephrotic syndrome (SRNS) Establishing a diagnosis of hereditary SRNS Guiding treatment decisions in individuals with nephrotic syndrome
F2ISO - Overview: F2-Isoprostanes, Random, Urine
Assessment of in vivo lipid peroxidation Considered to be an index of systemic oxidative stress over time
AFXN - Overview: Friedreich Ataxia, Repeat Expansion Analysis, Varies
Molecular confirmation of clinically suspected Friedreich ataxia
FAO - Overview: Fatty Acid Oxidation Probe Assay, Fibroblast Culture
In vitro confirmation of biochemical diagnoses of the following fatty acid oxidation disorders: -Short-chain acyl-CoA dehydrogenase deficiency -Medium-chain acyl-CoA dehydrogenase deficiency -Long-chain 3-hydroxyacyl-CoA dehydrogenase...
FFPG - Overview: Fruit Panel IgG
Fruit Panel IgG
FIBRO - Overview: FibroTest-ActiTest, Serum
Evaluating hepatic fibrosis in chronic hepatitis C patients Diagnosing fibrosis in carriers of chronic hepatitis B virus Evaluating hepatic fibrosis in co-infected HIV carriers Providing access to new-generation non-interferon...
FFLUR - Overview: Flurazepam (Dalmane) and Desalkylflurazepam
Flurazepam (Dalmane) and Desalkylflurazepam
FMBNY - Overview: Fetomaternal Bleed, New York, Blood
Determining the volume of fetal-to-maternal hemorrhage for the purposes of recommending an increased dose of the Rh immune globulin This test is used only for specimens collected in New York state.